Airsculpt Technologies, Inc.
Company Stats
- Market Cap
- $126.9M
- as of Sep 30, 2026
- Enterprise Value
- $175.4M
- Shares Outstanding
- 72.1M
- Free Float
- 46.6%
Income Statement
- Revenue
- $151.8M
- Operating Income
- -$11.6M
- Net Income
- -$11.7M
- EBITDA
- $1.2M
- Non-cash Impairment
- $6.7M
- Revenue Growth, 3Y
- -3.5%
- FCF Margin, 3Y Avg
- 2.0%
- FCF Margin, Worst Year
- -1.5%
Cash Flow
- Free Cash Flow
- $692,000
- FCF Yield
- 0.5%
- Owner FCF Yield
- -1.3%
Balance Sheet
- Cash & Equivalents
- $8.4M
- Total Debt
- $57.0M
- Net Debt
- $48.5M
- Net Debt / EBITDA
- 39.73x
- EV / EBITDA
- 143.65x
Returns & Capital
- SBC, 3Y Avg
- $8.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $151.8M | $692,000 | 0.5% |
| FY2024 | $180.3M | -$2.7M | -1.5% |
| FY2023 | $195.9M | $14.0M | 7.2% |
| FY2022 | $168.8M | $11.5M | 6.8% |
| FY2021 | $133.3M | $19.5M | 14.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground
July 4, 2026
Filings Beige Book
Companies Report Firm Demand, Relentless Cost Pressure
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground
July 4, 2026
Filings Beige Book
Companies Report Firm Demand, Relentless Cost Pressure